The FDA user fee reauthorization bill’s swift cruise through Congress did not appear to translate into signing speed upon arrival at the White House.
FDASIA Is Signed, Not That White House Wanted Anyone To Notice
White House sends out short press release as FDA is conducting an unrelated briefing to announce the user fee bill was enacted, surprising stakeholders and generating political questions.